tradingkey.logo

DSS Inc

DSS

0.910USD

+0.050+5.81%
Close 06/25, 16:00ETQuotes delayed by 15 min
8.27MMarket Cap
LossP/E TTM

DSS Inc

0.910

+0.050+5.81%
More Details of DSS Inc Company
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.
Company Info
Ticker SymbolDSS
Company nameDSS Inc
IPO dateOct 27, 1993
Founded at1984
CEOMr. Jason Grady
Number of employees100
Security typeOrdinary Share
Fiscal year-endOct 27
Address275 Wiregrass Pkwy
CityWEST HENRIETTA
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code14586
Phone15852321500
Websitehttps://www.dssworld.com/
Ticker SymbolDSS
IPO dateOct 27, 1993
Founded at1984
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
24.12M
93.00%
International
1.82M
7.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
13.06%
Global Biomedical Pte Ltd.
3.43%
Heuszel (Frank D.)
0.72%
Citadel Advisors LLC
0.64%
Other
42.01%
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
13.06%
Global Biomedical Pte Ltd.
3.43%
Heuszel (Frank D.)
0.72%
Citadel Advisors LLC
0.64%
Other
42.01%
Shareholder Types
Shareholders
Proportion
Corporation
43.57%
Individual Investor
13.78%
Hedge Fund
0.98%
Investment Advisor/Hedge Fund
0.46%
Investment Advisor
0.37%
Other
40.84%
Institutional Shareholding
Updated: Mon, Mar 3
Updated: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
42
5.34M
58.69%
-78.37K
2024Q4
44
5.34M
75.51%
+934.13K
2024Q3
50
4.36M
61.72%
-49.38K
2024Q2
55
4.37M
61.87%
-23.78K
2024Q1
58
4.35M
61.59%
-43.12K
2023Q4
57
4.38M
62.50%
-18.04K
2023Q3
61
4.33M
61.80%
-325.98K
2023Q2
66
4.33M
62.32%
-279.86K
2023Q1
73
4.27M
61.44%
-358.54K
2022Q4
74
4.28M
61.51%
-341.22K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Alset Ehome International Inc
3.65M
40.14%
--
--
Feb 06, 2025
Chan (Heng Fai Ambrose)
2.19M
24.06%
+1.00M
+84.21%
Feb 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Feb 06, 2025
Heuszel (Frank D.)
65.64K
0.72%
--
--
Aug 30, 2024
Renaissance Technologies LLC
25.25K
0.28%
+2.00K
+8.60%
Dec 31, 2024
The Vanguard Group, Inc.
43.32K
0.48%
-36.99K
-46.06%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
12.51K
0.14%
--
--
Dec 31, 2024
Ferguson Wellman Capital Management, Inc.
12.75K
0.14%
-12.75K
-50.00%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
Date
Type
Ratio
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
Nov 08, 2023
Merger
20<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
May 05, 2020
Merger
30<1
KeyAI